Details for New Drug Application (NDA): 211031
✉ Email this page to a colleague
The generic ingredient in EXEMESTANE is exemestane. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the exemestane profile page.
Summary for 211031
Tradename: | EXEMESTANE |
Applicant: | Breckenridge |
Ingredient: | exemestane |
Patents: | 0 |
Pharmacology for NDA: 211031
Mechanism of Action | Aromatase Inhibitors |
Suppliers and Packaging for NDA: 211031
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EXEMESTANE | exemestane | TABLET;ORAL | 211031 | ANDA | Breckenridge Pharmaceutical, Inc. | 51991-005 | 51991-005-90 | 90 TABLET, FILM COATED in 1 BOTTLE (51991-005-90) |
EXEMESTANE | exemestane | TABLET;ORAL | 211031 | ANDA | Bryant Ranch Prepack | 63629-2056 | 63629-2056-1 | 30 TABLET, FILM COATED in 1 BOTTLE (63629-2056-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Feb 21, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription